Development of an innovative mammalian USP manufacturing platform for therapeutic biologics.

Research unit

INNOSUISSE

Project number

34741.1 IP-LS

Project title

Development of an innovative mammalian USP manufacturing platform for therapeutic biologics.

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Category	Text
Short description (German)	Development of an innovative mammalian USP manufacturing platform for therapeutic biologics.
Short description (English)	Development of an innovative mammalian USP manufacturing platform for therapeutic biologics.
Abstract (German)	HES-SO Valais/Wallis and Ferring Pharmaceuticals are developing an innovative and cost-effective mammalian USP platform for therapeutic biologics. Proof-of-concept will be achieved by applying the development to the manufacturing of new therapeutic protein to be marketed.